Signia Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Lyon
Industry:Health servicesPharma
Business model:B2B
Signia Therapeutics is a medical company from France that develops a solution used to identify and repurpose rapidly, efficiently and at low cost already marketed drugs or to recycle unused drugs for new antiviral indication against several human respiratory viruses.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 1.51M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Signia Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Oui
47%
|
|
![]() |
Synklino
47%
|
|
![]() |
AttgeNO
47%
|
|
![]() |
Pharmanest
47%
|
|
![]() |
Betagenon
47%
|
|
![]() |
Stardots
47%
|
|
![]() |
ABC Transfer
47%
|
|
![]() |
PharmNovo
47%
|
|
![]() |
Ilya Pharma
47%
|
|
![]() |
Origo Biopharma
47%
|
|